mycoplasma
pneumonia
cell
wallless
bacteri
pathogen
human
respiratori
tract
account
communityacquir
pneumonia
cap
present
effect
mean
detect
straintyp
quantit
polymeras
chain
reaction
qpcr
exhibit
excel
sensit
specif
requir
separ
test
detect
genotyp
lack
standard
avail
test
lab
limit
practic
widespread
pointofcar
use
develop
previous
describ
silver
nanorod
arraysurfac
enhanc
raman
spectroscopi
naser
biosens
platform
capabl
detect
pneumonia
statist
signific
specif
sensit
simul
true
clinic
throat
swab
sampl
abil
distinguish
refer
strain
two
main
genotyp
pneumonia
furthermor
establish
qualit
lower
endpoint
detect
naser
genom
equival
quantit
multivari
detect
limit
demonstr
use
partial
least
squaresdiscriminatori
analysi
plsda
sampl
spectra
naser
correctli
identifi
pneumonia
clinic
isol
global
divers
origin
distinguish
panel
human
commens
pathogen
mycoplasma
speci
crossvalid
statist
accuraci
furthermor
plsda
correctli
classifi
strain
type
clinic
isol
crossvalid
accuraci
type
strain
crossvalid
accuraci
type
strain
crossvalid
accuraci
type
strain
cell
wallless
prokaryot
mycoplasma
pneumonia
major
caus
respiratori
diseas
human
account
commun
acquir
pneumonia
cap
pneumonia
lead
caus
cap
older
children
young
adult
incid
infect
young
elderli
rise
adult
alon
annual
econom
burden
cap
billion
macrolid
resist
grow
concern
particularli
children
extrapulmonari
sequela
occur
infect
final
evid
continu
indic
contribut
role
pneumonia
infect
onset
exacerb
recurr
asthma
area
grow
interest
role
pneumonia
strain
type
pathogenesi
diseas
epidemiolog
genet
divers
rel
limit
among
pneumonia
strain
categor
two
major
group
type
type
base
variat
within
sequenc
gene
although
variant
strain
two
increasingli
common
protein
import
virul
factor
immunogen
pneumonia
infect
must
complex
sever
protein
order
local
tip
termin
organel
mediat
receptor
bind
attach
respiratori
epithelium
essenti
step
success
colon
airway
variat
gene
sequenc
use
distinguish
type
type
strain
pneumonia
littl
known
phenotyp
differ
aris
genet
variat
perhap
notabl
regard
period
typeswitch
occur
two
major
genotyp
regular
pattern
four
seven
year
pneumonia
infect
transmit
aerosol
respiratori
secret
spread
slowli
effici
close
live
quarter
incub
period
three
week
symptom
tend
nondescript
often
complex
variabl
clinic
present
make
definit
diagnosi
challeng
result
diagnosi
often
presumpt
reli
heavili
combin
physic
find
elimin
possibl
caus
success
rate
laboratori
cultur
poor
even
experienc
lab
serolog
test
histor
consid
foundat
diagnosi
pneumonia
infect
limit
sensit
specif
high
tendenc
falseneg
requir
pair
sera
result
retrospect
diagnosi
must
often
pair
anoth
diagnost
method
current
exist
altern
effici
mean
detect
quantit
polymeras
chain
reaction
qpcr
present
fdaapprov
test
clinic
detect
pneumonia
illumigen
autom
detect
system
meridian
bioscienc
inc
cincinatti
ohio
filmarray
respiratori
panel
biofir
diagnost
inc
salt
lake
citi
utah
illumigen
platform
use
loopmedi
isotherm
amplif
capabl
detect
pneumonia
throat
nasopharyng
swab
specimen
high
degre
sensit
specif
filmarray
respiratori
panel
employ
nest
multiplex
qpcr
endpoint
melt
curv
analysi
nasopharyng
swab
test
differ
viral
bacteri
respiratori
pathogen
capabl
detect
pneumonia
low
colonyform
unit
cfu
ml
current
standard
pneumonia
genotyp
pcrrestrict
fragment
length
polymorph
also
done
nest
pcr
sequenc
multilocu
variablenumb
tandemrepeat
analysi
qpcr
high
resolut
melt
curv
analysi
method
detect
genotyp
exhibit
high
sensit
specif
known
strain
variant
allow
detect
earli
stage
infect
perform
hospit
refer
laboratori
howev
requir
separ
test
detect
genotyp
well
cost
complex
expertis
requir
limit
practic
widespread
pointofcar
use
limit
creat
critic
barrier
accur
time
diagnosi
pneumonia
infect
epidemiolog
track
rapid
simpl
diagnost
platform
capabl
simultan
detect
genotyp
would
greatli
improv
control
pneumonia
diseas
vibrat
spectroscopi
inher
biochem
specif
led
consider
nextgener
platform
rapid
detect
character
identif
infecti
agent
raman
spectroscopi
particular
sever
advantag
applic
biolog
sampl
includ
narrow
bandwidth
good
spatial
resolut
abil
analyz
aqueou
sampl
due
absenc
interfer
water
molecul
furthermor
raman
spectra
provid
detail
structur
inform
chemic
composit
sampl
serv
characterist
molecular
fingerprint
pathogen
identif
despit
advantag
standard
raman
spectra
inher
limit
weak
signal
detect
result
applic
tradit
raman
spectroscopi
biosens
applic
impract
ineffici
discoveri
sampl
adsorpt
onto
nanoscop
roughen
metal
surfac
result
signific
enhanc
raman
signal
spectral
intens
enhanc
factor
fold
attribut
increas
electromagnet
field
molecul
close
proxim
metal
surfac
surfaceenhanc
raman
spectroscopi
ser
retain
advantag
standard
raman
spectroscopi
addit
markedli
improv
sensit
allow
consider
success
whole
organ
molecular
fingerprint
inconsist
lack
reproduc
prepar
sersact
substrat
hinder
widespread
use
biosens
applic
howev
highli
order
silver
nanorod
array
na
substrat
fabric
use
obliqu
angl
deposit
oad
yield
consist
ser
enhanc
factor
around
less
variat
substrat
batch
reproduc
naser
substrat
improv
pattern
multiwel
format
polydimethylsiloxan
pdm
highli
reproduc
detect
capabl
naser
well
demonstr
multipl
infecti
agent
includ
rsv
rotaviru
influenza
hiv
adenoviru
sar
coronaviru
pneumonia
hennigan
et
al
describ
nasersbas
platform
capabl
detect
pneumonia
statist
signific
sensit
specif
simul
true
clinic
throat
swab
potenti
detect
type
pneumonia
within
singl
test
recent
determin
sensit
naser
pneumonia
detect
genom
equival
qualit
quantit
multivari
detect
limit
initi
evalu
biosens
platform
capabl
indic
potenti
applic
nextgener
diagnost
tool
clinic
detect
pneumonia
comprehens
analysi
need
prior
proceed
clinic
valid
present
studi
explor
specif
naser
pneumonia
detect
panel
pneumonia
isol
collect
repres
global
outbreak
span
clinic
relev
genotyp
furthermor
sinc
naser
inher
biochem
specif
analyz
panel
human
commens
pathogen
mycoplasma
demonstr
biosens
platform
could
distinguish
pneumonia
clinic
relev
closest
phylogenet
rel
final
evalu
abil
naser
platform
correctli
type
pneumonia
clinic
isol
rel
known
refer
strain
pneumonia
wild
type
pneumonia
refer
strain
type
fh
type
grown
harvest
prepar
univers
georgia
uga
studi
panel
addit
clinic
isol
consist
type
strain
type
strain
six
type
variant
strain
grown
harvest
prepar
ser
qualiti
control
analysi
pneumonia
respons
surveil
laboratori
center
diseas
control
prevent
cdc
atlanta
georgia
genotyp
group
determin
pneumonia
respons
surveil
laboratori
cdc
atlanta
ga
use
dna
sequenc
analysi
qpcr
combin
high
resolut
melt
curv
analysi
rflp
sequenc
analysi
mycoplasma
isol
control
cultur
medium
tissu
cultur
flask
inocul
incub
strain
grown
uga
harvest
log
phase
phenol
red
indic
turn
orang
color
upon
reach
ph
strain
grown
cdc
harvest
day
date
inocul
ensur
adequ
growth
isol
time
harvest
spent
growth
medium
decant
flask
volum
steril
pb
ph
ad
wash
adher
mycoplasma
pb
wash
decant
pb
wash
repeat
cell
scrape
ml
steril
pb
cell
syringepassag
gaug
needl
aliquot
made
determin
protein
content
plate
pplo
agar
cfu
determin
select
isol
control
dna
extract
genom
equival
determin
ser
analysi
pneumonia
sampl
ser
analysi
syringepassag
needl
dispers
clump
fix
addit
one
volum
formaldehyd
steril
pb
ph
store
growth
medium
neg
control
sampl
prepar
parallel
condit
pneumonia
refer
strain
describ
previous
time
ser
analysi
mycoplasma
mediumonli
neg
control
sampl
dilut
steril
di
water
concentr
fall
within
ser
detect
rang
pneumonia
found
dilut
enough
ensur
spectra
adequ
repres
ser
raman
spectra
aris
ag
nanorod
substrat
sampl
load
onto
naser
substrat
immedi
follow
dilut
prepar
nonm
pneumonia
human
commens
pathogen
speci
naser
analysi
twelv
human
commens
pathogen
mollicut
speci
close
relat
pneumonia
grown
harvest
univers
alabama
birmingham
uab
mycoplasma
buccal
mycoplasma
lipophilum
mycoplasma
faucium
origin
intend
includ
panel
attempt
cultur
organ
unsuccess
cultur
ml
stock
cultur
inocul
approxim
ml
hayflick
depend
individu
speci
growth
requir
incub
ph
indic
chang
color
indic
microbi
growth
util
metabol
substrat
media
ie
glucos
arginin
urea
time
harvest
cell
spent
media
pour
ml
polycarbon
tube
centrifug
rpm
min
except
ureaplasma
speci
centrifug
hr
supernat
decant
pellet
suspend
ml
steril
pb
cell
wash
centrifug
rpm
min
rpm
hr
ureaplasma
speci
supernat
decant
pellet
suspend
ml
steril
pb
transfer
ml
vial
centrifug
rpm
min
supernat
decant
pellet
suspend
ml
steril
pb
syringepassag
use
needl
dispers
clump
aliquot
made
spot
onto
blood
agar
plate
test
contamin
plate
cfu
colorchang
unit
ccu
determin
two
aliquot
centrifug
rpm
min
supernat
remov
pellet
frozen
shipment
uga
store
ser
qualiti
control
analysi
cell
pellet
suspend
ml
steril
pb
ph
syringepassag
gaug
needl
dispers
clump
aliquot
made
dna
extract
genom
equival
determin
protein
assay
naser
analysi
ser
sampl
prepar
fix
suspend
cell
formaldehyd
steril
pb
ph
store
time
ser
analysi
time
sampl
dilut
steril
di
water
concentr
immedi
load
onto
naser
substrat
growth
medium
neg
control
pneumonia
strain
sampl
prepar
describ
comparison
sampl
analyz
protein
content
via
bicinchonin
acid
assay
dna
extract
qiaamp
dna
blood
minikit
qiagen
valencia
ca
use
blood
bodi
fluid
protocol
includ
rnase
treatment
sampl
use
dna
extract
final
elut
volum
use
quantifi
dna
content
genom
equival
genom
dna
concentr
absorb
measur
bicinchonin
acid
assay
perform
nanodrop
instrument
model
thermo
scientif
wilmington
de
use
softwar
genom
equival
pneumonia
sampl
calcul
dna
concentr
obtain
analysi
use
previous
determin
mass
pneumonia
genom
dalton
genom
equival
nonm
pneumonia
sampl
determin
dna
concentr
obtain
analysi
genom
mass
calcul
studi
base
publish
genom
length
known
gc
content
genbank
databas
naser
substrat
prepar
oad
describ
prior
use
substrat
clean
min
ar
plasma
use
plasma
cleaner
model
harrick
plasma
ithaca
ny
remov
surfac
contamin
pattern
diamet
pdmsform
well
ethylen
bpe
molar
methanol
use
extern
control
ensur
consist
substrat
raman
spectra
acquir
use
renishaw
invia
reflex
multiwavelength
confoc
imag
microscop
hoffman
estat
il
leicha
apochromat
object
na
illumin
area
substrat
allow
spatial
averag
minim
effect
potenti
random
hot
spot
nearinfrar
diod
laser
renishaw
oper
power
capac
mw
provid
incom
radiat
spectra
collect
acquisit
intern
silicon
standard
measur
obtain
begin
ser
analysi
intern
control
instrument
perform
sampl
appli
duplic
na
substrat
concentr
specifi
volum
per
well
allow
dri
overnight
spectra
collect
five
random
locat
within
sampl
spot
analysi
total
spectra
per
sampl
pneumonia
refer
strain
growth
medium
control
independ
prepar
analyz
substrat
two
well
per
substrat
intent
left
blank
obtain
background
ser
read
nake
nanorod
substrat
total
three
separ
na
substrat
use
experi
two
analysi
pneumonia
isol
n
spectra
one
analysi
human
commens
mollicut
speci
n
spectra
result
total
n
spectra
spectra
deliber
collect
multipl
locat
within
singl
substrat
well
multipl
substrat
ensur
inher
varianc
present
substrat
impact
result
raman
spectra
cm
acquir
use
renishaw
wire
softwar
instrument
set
optim
maxim
signal
minim
satur
sampl
degrad
aris
laser
stimul
raman
spectra
first
averag
use
spectral
softwar
packag
galact
industri
nashua
nh
order
assess
signaltonois
qualiti
baselinecorrect
use
concav
rubberband
algorithm
perform
iter
point
aid
preliminari
evalu
spectra
peak
assign
opu
bruker
optic
inc
billerica
chemometr
analysi
carri
matlab
version
mathwork
inc
natick
use
plstoolbox
version
eigenvector
research
inc
wenatche
wa
raw
spectra
preprocess
use
st
deriv
spectrum
nd
order
polynomi
savitskygolay
algorithm
dataset
vectornorm
meancent
due
inher
complex
natur
spectral
data
multivari
statist
analysi
dataset
perform
use
princip
compon
analysi
pca
partial
least
squaresdiscriminatori
analysi
plsda
use
pl
toolbox
softwar
unless
otherwis
specifi
plsda
model
crossvalid
use
venetian
blind
algorithm
data
split
plsda
model
studi
exclud
individu
sampl
analysi
gener
use
total
spectra
per
model
analyz
clinic
isol
includ
refer
strain
type
fh
type
alongsid
growth
medium
control
prepar
parallel
pneumonia
sampl
full
detail
regard
isol
origin
year
genotyp
macrolid
suscept
protein
dna
content
genom
equival
pneumonia
strain
given
tabl
cfu
valu
determin
refer
strain
six
randomli
chosen
addit
isol
assess
cell
viabil
time
fixat
rang
cfuml
due
propens
mycoplasma
cell
clump
confound
factor
use
cfu
valu
metric
sampl
content
potenti
discrep
cfu
valu
actual
cell
number
differ
much
fold
therefor
protein
content
genom
equival
determin
order
better
defin
content
sampl
concentr
analyz
ser
valu
fell
within
compar
rang
consist
publish
valu
bacteri
cell
protein
concentr
per
cell
higher
pneumonia
isol
harvest
stationari
phase
rel
harvest
log
phase
growth
phase
base
color
ph
indic
medium
notabl
differ
genom
equival
ser
spectra
observ
pneumonia
sampl
rel
growth
phase
time
harvest
data
shown
averag
ser
spectra
nanorod
substrat
background
growth
medium
control
pneumonia
sampl
shown
fig
class
exhibit
distinct
band
pattern
expect
plsda
appli
determin
statist
signific
detect
pneumonia
naser
plsda
fullspectrum
multivari
supervis
statist
method
wherebi
prior
knowledg
class
use
yield
robust
discrimin
minim
variat
within
class
emphas
latent
variabl
aris
spectral
differ
class
plsda
model
gener
discrimin
three
class
nanorod
substrat
background
fig
growth
medium
control
fig
pneumonia
strain
fig
inclus
substrat
background
growth
medium
control
allow
us
ensur
differ
growth
medium
nanorod
background
signal
within
substrat
affect
abil
model
discrimin
presenc
absenc
pneumonia
two
nanorod
substrat
use
experi
contain
duplic
well
bare
nanorod
substrat
independ
prepar
fh
growth
medium
control
addit
clinic
isol
pneumonia
total
n
preprocess
naser
spectra
collect
substrat
includ
model
consist
nanorod
substrat
background
spectra
growth
medium
control
spectra
spectra
fh
spectra
spectra
per
addit
clinic
isol
crossvalid
statist
model
show
naser
correctli
classifi
clinic
isol
pneumonia
regardless
global
origin
year
isol
genotyp
macrolid
suscept
phenotyp
distinguish
substrat
background
growth
medium
control
crossvalid
sensit
specif
critic
question
clinic
detect
platform
specif
pathogen
interest
particularli
context
organ
potenti
present
clinic
sampl
ser
structurebas
techniqu
gener
raman
fingerprint
barcod
base
uniqu
molecular
content
sampl
like
organ
gener
fals
posit
would
close
resembl
pneumonia
structur
evalu
specif
naser
biosens
platform
human
commens
pathogen
mollicut
speci
close
relat
pneumonia
rpob
nucleotid
amino
acid
sequenc
phylogeni
rdna
phylogeni
chosen
analysi
alongsid
pneumonia
strain
growth
medium
control
order
best
defin
content
sampl
concentr
use
ser
analys
done
determin
total
protein
dna
content
latter
allow
calcul
genom
equival
base
known
genom
size
gc
content
tabl
fell
within
compar
rang
consist
publish
valu
bacteri
cell
goal
develop
plsda
model
distinguish
pneumonia
panel
closelyrel
mollicut
speci
might
found
human
total
n
preprocess
naser
spectra
collect
singl
nanorod
substrat
consist
n
substrat
background
spectra
n
growth
medium
control
spectra
n
pneumonia
spectra
spectra
per
mollicut
speci
initi
plsda
model
gener
discrimin
two
class
nanorod
substrat
background
biolog
sampl
crossvalid
sensit
dot
line
indic
classif
threshold
line
posit
class
predict
blackdot
line
indic
confid
interv
crossvalid
sensit
specif
class
error
panel
follow
nanorod
substrat
background
respect
b
growth
medium
control
respect
c
pneumonia
respect
crossvalid
statist
obtain
use
venetian
blind
data
split
repres
predict
perform
plsda
model
pneumonia
detect
specif
data
shown
purpos
model
ensur
nanorod
substrat
background
signal
significantli
differ
sampl
order
exclud
background
spectra
futur
model
determin
nanorod
substrat
background
class
could
exclud
second
plsda
model
gener
use
spectra
distinguish
among
three
class
growth
medium
control
pneumonia
mollicut
speci
model
total
n
preprocess
naser
spectra
consist
n
growth
medium
control
spectra
n
pneumonia
spectra
spectra
per
mollicut
speci
model
distinguish
three
class
crossvalid
sensit
specif
data
shown
upon
success
develop
plsda
model
distinguish
growth
medium
control
pneumonia
mollicut
speci
final
plsda
model
gener
use
preprocess
naser
spectra
three
nanorod
substrat
analyz
experi
model
contain
total
n
spectra
consist
growth
medium
control
spectra
spectra
fh
spectra
spectra
per
pneumonia
clinic
isol
isol
total
spectra
per
mollicut
speci
speci
total
model
also
categor
three
class
growth
medium
control
fig
pneumonia
clinic
isol
includ
refer
strain
fig
mollicut
speci
fig
plsda
distinguish
pneumonia
strain
human
mollicut
speci
growth
medium
control
crossvalid
sensit
specif
fig
key
advantag
naser
biosens
potenti
detect
type
organ
singl
test
especi
interest
sinc
current
exist
platform
capabl
simultan
detect
type
pneumonia
evalu
capabl
appli
plsda
pneumonia
strain
spectra
panel
clinic
isol
contain
three
distinct
clinic
relev
genotyp
pneumonia
type
strain
type
strain
six
type
variant
strain
pneumonia
strain
type
fh
type
use
refer
strain
control
previous
appli
manner
evalu
pneumonia
genotyp
assay
type
strain
plsda
model
gener
use
preprocess
naser
spectra
consist
spectra
fh
spectra
control
spectra
type
clinic
isol
sampl
spectra
per
isol
total
spectra
model
built
discrimin
class
either
type
type
plsda
abl
correctli
classifi
type
strain
type
refer
strain
sensit
specif
fig
type
strain
second
plsda
model
gener
use
preprocess
naser
spectra
consist
type
refer
strain
control
spectra
spectra
type
clinic
isol
sampl
spectra
per
isol
total
spectra
model
likewis
built
discrimin
class
either
type
type
plsda
abl
correctli
classifi
type
isol
type
refer
strain
control
sensit
specif
fig
type
clinic
isol
third
plsda
model
gener
use
preprocess
naser
spectra
consist
type
refer
strain
control
spectra
spectra
type
clinic
isol
sampl
spectra
per
isol
total
spectra
howev
model
built
discrimin
class
type
refer
strain
control
type
refer
strain
control
type
clinic
isol
spectra
third
class
necessari
classif
genotyp
exist
method
capabl
identifi
variant
strain
uniqu
type
isol
strain
clinic
purpos
naser
type
abl
plsda
correctli
classifi
type
refer
strain
control
distinct
type
control
type
clinic
isol
crossvalid
sensit
crossvalid
specif
fig
furthermor
plsda
distinguish
type
refer
strain
control
type
control
clinic
isol
crossvalid
sensit
specif
respect
fig
lastli
plsda
correctli
classifi
six
type
strain
distinct
type
refer
strain
control
crossvalid
sensit
specif
fig
drop
sensit
specif
observ
type
refer
strain
control
like
due
fact
variant
strain
type
parent
strain
variant
strain
tend
similar
respect
parent
strain
genet
either
opposit
strain
type
evalu
strain
type
capabl
naser
plsda
model
gener
use
fh
refer
strain
alongsid
clinic
isol
individu
thirti
plsda
model
built
use
type
spectra
type
fh
spectra
refer
strain
control
class
clinic
isol
spectra
treat
unknown
class
type
clinic
isol
two
categori
use
crossvalid
model
type
isol
strain
three
categori
incorpor
crossvalid
model
describ
clinic
isol
type
model
crossvalid
use
venetian
blind
algorithm
seven
data
split
plsda
model
incorpor
simul
potenti
strategi
futur
applic
naser
pneumonia
genotyp
wherein
known
strain
type
control
use
predict
genotyp
unknown
clinic
sampl
full
crossvalid
statist
plsda
model
given
tabl
type
clinic
isol
tabl
type
clinic
isol
overal
plsda
perform
consist
model
shown
fig
notabl
differ
perform
decreas
crossvalid
specif
individu
model
type
clinic
isol
like
aris
due
decreas
sampl
size
n
use
build
individu
plsda
model
addit
compar
averag
baselinecorrect
normal
spectra
three
genotyp
look
differ
band
pattern
three
genotyp
could
contribut
classif
capabl
demonstr
plsda
model
fig
major
spectral
fingerprint
ident
three
strain
type
expect
sinc
speci
classifi
plsda
model
shown
fig
howev
sever
visibl
differ
band
pattern
present
spectra
genotyp
pneumonia
could
account
abil
naser
distinguish
three
genotyp
statist
signific
sensit
specif
averag
type
spectrum
two
uniqu
peak
one
cm
appear
averag
type
spectra
one
cm
appear
distinct
shift
slightli
right
type
spectrum
compar
type
spectrum
appear
type
spectrum
averag
type
strain
spectrum
similar
type
strain
spectrum
asid
differ
mention
presenc
doublet
cm
appear
distinct
present
type
spectrum
pneumonia
spectra
open
shape
differ
cluster
indic
differ
individu
strain
isol
human
commens
pathogen
mollicut
speci
repres
light
gray
shape
differ
cluster
indic
individu
speci
reddot
line
indic
classif
threshold
line
posit
class
predict
blackdot
line
indic
confid
interv
crossvalid
sensit
specif
class
error
panel
follow
growth
medium
control
respect
b
pneumonia
sampl
respect
c
mollicut
speci
respect
crossvalid
statist
obtain
use
venetian
blind
data
split
repres
predict
perform
plsda
model
pneumonia
detect
broad
singlet
type
spectrum
averag
type
spectrum
appear
distinct
three
doublet
cm
appear
singl
peak
type
spectra
small
peak
also
absent
type
spectra
spectral
differ
extrem
subtl
chemometr
analysi
highli
capabl
discern
differ
substanti
discriminatori
classif
power
although
littl
known
phenotyp
effect
strain
type
beyond
observ
differ
biofilm
format
genotyp
differ
well
character
briefli
homolog
recombin
within
gene
repetit
element
sequenc
locat
outsid
gene
contribut
sequenc
variat
strain
type
indic
individu
clinic
isol
strainisol
design
indic
bracket
cluster
reddot
line
indic
classif
threshold
line
posit
class
predict
blackdot
line
indic
confid
interv
crossvalid
sensit
specif
class
error
panel
ac
obtain
use
venetian
blind
data
split
repres
predict
perform
type
strain
respect
b
type
strain
respect
c
type
strain
respect
two
categori
use
crossvalid
model
either
type
type
clinic
isol
treat
unknown
class
crossvalid
sensit
specif
class
error
base
classif
predict
score
respect
refer
strain
control
class
cv
crossvalid
nucleotid
amino
acid
sequenc
pneumonia
isol
indic
trinucleotid
short
sequenc
repeat
ssr
code
serin
found
strain
type
anywher
time
appear
preval
type
strain
serin
repeat
may
form
hing
structur
lead
downstream
conform
differ
protein
differ
strain
type
could
potenti
affect
interact
host
surfac
antigen
addit
isol
zhao
et
al
studi
point
mutat
sever
variant
strain
correspond
amino
acid
chang
glutamin
prolin
asparagin
isoleucin
residu
studi
peak
uniqu
type
spectrum
commonli
associ
vibrat
mode
bond
present
lysin
cm
amid
alpha
helix
cm
molecular
structur
peak
uniqu
type
spectral
fingerprint
locat
cm
commonli
associ
vibrat
mode
found
histidin
tryptophan
carbohydr
bond
final
peak
uniqu
type
clinic
isol
found
cm
frequent
associ
bond
present
histidin
tryptophan
ribos
indol
asparagin
methionin
glutamin
ss
cc
stretch
vibrat
mode
interestingli
uniqu
peak
present
averag
spectra
strain
type
analyz
studi
predomin
associ
protein
backbon
amino
acid
residu
dna
bond
vibrat
furthermor
spectral
featur
averag
spectrum
variant
strain
consist
point
mutat
identifi
zhao
et
al
studi
overal
spectral
interpret
averag
spectra
strain
type
consist
known
differ
strain
type
pneumonia
infect
unsupervis
chemometr
analysi
pneumonia
strain
type
mollicut
speci
appli
pca
supplement
plsda
model
sampl
spectra
evalu
total
varianc
present
pneumonia
type
human
commens
pathogen
mollicut
dataset
pca
unsupervis
form
chemometr
analysi
reduc
dimension
dataset
facilit
establish
pattern
group
similar
spectra
without
priori
knowledg
sampl
class
pca
explain
success
smaller
proport
varianc
first
princip
compon
explain
greatest
percentag
total
varianc
present
dataset
preprocess
ser
spectra
pneumonia
refer
strain
type
control
type
clinic
isol
use
gener
pca
plot
compar
principl
compon
captur
total
varianc
present
spectra
use
build
model
fig
type
control
strain
fh
cluster
bottom
right
corner
cluster
pattern
type
strain
predomin
left
though
overlap
two
strain
type
present
pca
model
type
clinic
isol
support
plsda
model
spectra
shown
fig
fig
comparison
averag
baselinecorrect
normal
ser
spectra
type
type
type
genotyp
raw
spectra
type
n
type
n
type
n
clinic
isol
control
averag
baselinecorrect
normal
use
spectral
softwar
packag
galact
industri
nashua
nh
red
averag
spectrum
type
pneumonia
strain
green
averag
spectrum
type
pneumonia
strain
blue
averag
spectrum
type
pneumonia
strain
peak
uniqu
specif
genotyp
pneumonia
indic
arrow
identifi
spectral
fingerprint
type
peak
red
arrow
type
peak
green
arrow
type
peak
blue
arrow
inset
top
right
imag
depict
zoomedin
view
type
doublet
cm
second
pca
model
built
use
preprocess
ser
spectra
n
consist
type
refer
strain
control
type
clinic
isol
pneumonia
princip
compon
captur
total
varianc
plot
orthogon
show
distinct
separ
type
refer
strain
control
type
refer
strain
isol
littl
overlap
cluster
fig
pca
model
type
clinic
isol
dataset
consist
plsda
model
data
shown
fig
third
pca
model
built
use
preprocess
ser
spectra
type
clinic
isol
dataset
n
princip
compon
captur
total
varianc
plot
orthogon
show
distinctli
separ
cluster
type
control
type
control
type
clinic
isol
overlap
present
type
type
cluster
fig
cluster
pattern
support
plsda
classif
perform
shown
fig
final
pca
model
built
use
full
pneumonia
mollicut
speci
dataset
consist
preprocess
spectra
nanorod
array
substrat
n
princip
compon
captur
total
varianc
plot
orthogon
show
three
distinctli
separ
cluster
growth
medium
control
spectra
pneumonia
spectra
mollicut
speci
spectra
overlap
cluster
fig
support
plsda
model
data
shown
fig
final
question
interest
abil
platform
discrimin
among
differ
speci
analyz
studi
howev
plsda
classif
perform
diminish
number
class
question
increas
due
underli
algorithm
appli
tabl
crossvalid
plsda
model
statist
predict
perform
speci
discrimin
pneumonia
nine
human
commens
pathogen
mycoplasma
speci
individu
cv
sensit
cv
specif
cv
class
error
speci
discrimin
three
categori
incorpor
crossvalid
model
either
categori
growth
medium
control
gmc
categori
pneumonia
categori
mycoplasma
speci
question
eight
spectra
categori
known
class
two
spectra
categori
treat
unknown
gener
crossvalid
predict
model
crossvalid
sensit
specif
class
error
base
classif
predict
score
categori
model
attempt
classifi
speci
within
singl
plsda
model
fail
yield
statist
signific
accuraci
order
overcom
limit
address
question
clinic
relev
classif
system
individu
pairwis
plsda
model
employ
analysi
chose
focu
nine
human
commens
pathogen
mycoplasma
speci
close
relat
phylogent
pneumonia
individu
plsda
model
built
nine
mycoplasma
speci
distinguish
among
three
categori
growth
medium
control
pneumonia
mycoplasma
speci
question
model
contain
total
n
spectra
spectra
repres
categori
furthermor
categori
eight
spectra
known
sampl
class
wherea
two
spectra
treat
unknown
classifi
base
resembl
categori
spectra
crossvalid
predict
capabl
model
done
use
venetian
blind
algorithm
five
data
split
model
design
way
simul
predict
potenti
unknown
clinic
sampl
mycoplasmaneg
pneumoniaeposit
posit
one
human
commens
pathogen
mycoplasma
speci
crossvalid
sensit
specif
nine
model
given
tabl
overal
crossvalid
sensit
specif
greater
nine
model
promis
applic
naser
specieslevel
discrimin
predict
pneumonia
signific
human
respiratori
tract
pathogen
incid
public
health
impact
diagnost
strategi
complic
atyp
complex
present
diseas
nondescript
symptom
requir
separ
test
detect
genotyp
challeng
pose
direct
cultur
serolog
test
histor
gold
standard
diagnosi
suffer
sever
limit
make
unreli
impract
rapid
detect
advanc
qpcr
technolog
overcom
mani
issu
sensit
reliabl
cost
reagent
requir
technic
expertis
still
high
independ
test
must
done
detect
genotyp
limit
diagnosi
qpcr
hospit
advanc
laboratori
facil
make
impract
pointofcar
use
previous
establish
naser
biosens
platform
capabl
statist
signific
detect
pneumonia
true
simul
throat
swab
qualit
endpoint
detect
pneumonia
sensit
exceed
qpcr
naser
show
statist
signific
specif
pneumonia
detect
regardless
clinic
isol
origin
year
isol
macrolid
suscept
phenotyp
strain
type
also
abl
distinguish
pneumonia
clinic
isol
control
strain
human
commens
pathogen
mollicut
speci
furthermor
naser
discrimin
two
major
strain
type
pneumonia
high
degre
statist
signific
accuraci
correctli
identifi
variant
strain
differ
two
major
genotyp
importantli
naser
capabl
detect
straintyp
pneumonia
within
singl
test
thu
potenti
facilit
track
epidemiolog
trend
typeswitch
outbreak
period
studi
clinic
sampl
ongo
effect
presenc
clinic
relev
sampl
background
exampl
patient
throat
swab
abil
platform
identifi
strain
type
distinguish
pneumonia
human
commens
pathogen
mollicut
speci
remain
determin
furthermor
assess
altern
method
chemometr
analysi
account
increas
number
class
model
complex
specieslevel
discrimin
naser
necessari
addit
futur
clinic
applic
technolog
requir
collect
larger
spectral
librari
isol
background
control
howev
pointofcar
clinic
standpoint
abil
detect
pneumonia
rapidli
critic
inform
appropri
treatment
regimen
consist
respons
use
antimicrobi
featur
underscor
avail
handheld
raman
instrument
potenti
pointofcar
use
combin
minim
sampl
prepar
requir
expedi
detect
naser
show
great
promis
platform
futur
applic
pointofcar
pneumonia
diagnost
